A carregar...
Trial Watch: Immunostimulatory monoclonal antibodies for oncological indications
The goal of cancer immunotherapy is to establish new or boost pre-existing anticancer immune responses that eradicate malignant cells while generating immunological memory to prevent disease relapse. Over the past few years, immunomodulatory monoclonal antibodies (mAbs) that block co-inhibitory rece...
Na minha lista:
| Publicado no: | Oncoimmunology |
|---|---|
| Main Authors: | , , , , , |
| Formato: | Artigo |
| Idioma: | Inglês |
| Publicado em: |
Taylor & Francis
2017
|
| Assuntos: | |
| Acesso em linha: | https://ncbi.nlm.nih.gov/pmc/articles/PMC5706611/ https://ncbi.nlm.nih.gov/pubmed/29209572 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1080/2162402X.2017.1371896 |
| Tags: |
Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!
|